col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

82 Results       Page 1

Informa UK (Taylor & Francis): Journal of Dermatological Treatment
  original article Date Title Authors   All Authors
1 [GO] 2023―Dec―16 Single-institution retrospective review evaluating the impact of the Covid-19 pandemic on isotretinoin prescribing practices Dina Poplausky, Brandon R. Block, Annie Chang, Sach Thakker, Jade N. Young, Nicholas Gulati, Jonathan Ungar
2 [GO] 2023―Aug―10 A prospective randomized controlled trial of Psychodermatology on the efficacy of Rilastil Difesa Sterile® cream in the hand eczema of healthcare workers during the COVID-19 pandemic Federica Veronese, Elia Esposto, Chiara Airoldi, Carla Gramaglia, Lucia Bestagini, Elisa Zavattaro, et al. (+2)
3 [GO] 2023―Aug―02 SARS-CoV-2: an environmental trigger of Darier’s disease? Diego Orsini, Andrea D’Arino, Flavia Pigliacelli, Paolo Iacovelli, Alessia Pacifico, Carlo Cota, et al. (+2)
4 [GO] 2023―Mar―30 New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series Luigi Gargiulo, Luciano Ibba, Carlo A. Vignoli, Francesco Piscazzi, Andrea Cortese, Giovanni Fiorillo, et al. (+6)
5 [GO] 2023―Mar―17 High-risk Squamous Cell Carcinoma, a surgical challenge: the other face of the SARS-CoV-2 pandemic Alvaro Prados-Carmona, José María Llamas-Molina, Pablo Velasco-Amador, Ricardo Ruiz-Villaverde, José Carlos Ruiz-Carrascosa
6 [GO] 2023―Jan―10 Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients receiving secukinumab: a literature review Paolo Gisondi, David Simon, Ivette Alarcon, Effie Pournara, Lluís Puig
7 [GO] 2022―Dec―22 Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID) K.V. Kwee, J. Murk, Q. Yin, M.B Visch, L. Davidson, E.M.G.J. de Jong, et al. (+2)
8 [GO] 2022―Jun―20 Letter to the editor submitted in response to ‘Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study’ Maddalena Napolitano, Luca Potestio, Francesca Di Vico, Gabriella Fabbrocini, Cataldo Patruno
9 [GO] 2022―Apr―21 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study Brian D. Rankin, Jorge-Ryan Georgakopoulos, Muskaan Sachdeva, Asfandyar Mufti, Alim R. Devani, Melinda J. Gooderham, et al. (+6)
10 [GO] 2022―Feb―16 Remote consultations: an audit of the management of dermatology patients on biologics during the first wave of the COVID-19 pandemic Chiedu E. Ufodiama, Sarah J. J. Touyz, David A. Fitzgerald, Hamish J. A. Hunter, Emma McMullen, Richard B. Warren, C. Elise Kleyn
11 [GO] 2021―Jun―29 Future perspectives on care for patients with psoriasis. What did we learn during the COVID-19 Peter C. M. van de Kerkhof
12 [GO] 2021―May―25 The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey Selda Pelin Kartal, Gökçen Çelik, Oğuz Yılmaz, Eda Öksüm Solak, Büşra Demirbağ Gül, Tuba Kevser Üstünbaş, et al. (+23)
13 [GO] 2021―Mar―24 Risk of COVID-19 Infection, Hospitalization, and Mortality in Patients with Psoriasis Treated by Interleukin-17 Inhibitors Khalaf Kridin, Yochai Schonmann, Arie Solomon, Giovanni Damiani, Dana Tzur Bitan, Erez Onn, et al. (+2)
14 [GO] 2021―Feb―10 My patient refers smell/taste disturbance. It may not be COVID-19. Dermatological drugs associated with olfactory and/or gustative disorders Luiz Guilherme Martins Castro, Isabella Parente Almeida
15 [GO] 2021―Jan―26 Immunosuppressants, Immunomodulators and COVID-19 Vaccines: Anticipating Patient Concerns Jonathan Rick, Alyssa M. Thompson, Jennifer L. Hsiao, Wilson Liao, Vivian Y. Shi
16 [GO] 2020―Dec―30 Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris Zainab A. Jafri, Shikha Walia, Mirjana G. Ivanic, Jashin J. Wu
17 [GO] 2020―Dec―15 The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy P Ciechanowicz, K Dopytalska, A Mikucka-Wituszyńska, M Dźwigała, K Wiszniewski, W Herniczek, et al. (+2)
18 [GO] 2020―Oct―23 COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma M. Arenbergerova, S. Gkalpakiotis, P. Arenberger, A. Fialova, M. Pasek
19 [GO] 2020―Oct―15 Strategies to maximize clinical efficiency while maintaining patient safety during the COVID-19 pandemic: an interview-based study from private practice dermatologists Kaitlyn M. Yim, Rebecca M. Yim, Sara Gaspard, Jamie MacDougall, April W. Armstrong
20 [GO] 2020―Sep―07 Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic Mohammad Shahidi Dadras, Zohreh Ahmadzadeh, Shima Younespour, Fahimeh Abdollahimajd
21 [GO] 2020―Sep―03 Urticaria and COVID-19 infection: a critical appraisal- Reply Mohammed Shanshal
22 [GO] 2020―Sep―03 The reduction in the detection of melanoma during the coronavirus disease 2019 (COVID-19) pandemic in a Melanoma center of South Italy Alessia Villani, Gabriella Fabbrocini, Massimiliano Scalvenzi
23 [GO] 2020―Aug―12 Psychological teleconsultations in patients suffering from chronic skin diseases during the COVID-19 era: a service to improve patients’ quality of life Claudio Marasca, Anna De Rosa, Gabriella Fabbrocini, Mariateresa Cantelli, Angela Patrì, Maria Vastarella, et al. (+4)
24 [GO] 2020―Aug―08 Intralesional antigen immunotherapy for warts in the era of COVID-19 Ahmad Nofal, Mohamed M Fawzy, Ayman Abdelmaksoud, Esraa E El-Hawary
25 [GO] 2020―Aug―08 Urticaria and COVID-19 infection: a critical appraisal Yashdeep Singh Pathania
26 [GO] 2020―Aug―08 Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registries Mary Beth Gadarowski, Esther A. Balogh, Arjun M. Bashyam, Steven R. Feldman
27 [GO] 2020―Aug―08 Photo-triage of infantile haemangiomas: potential to reduce healthcare exposure in the COVID19 pandemic A Flynn, C O’Connor, M Murphy
28 [GO] 2020―Aug―04 Change of dermatological practice after the COVID-19 outbreak resolves Chuang Gao, Baoyi Liu, Yongyi Xie, Zhouwei Wu
29 [GO] 2020―Jul―29 The dermatology and aesthetic practices in the era of COVID-19 Khaled El-Hoshy, Mona El-Kalioby
30 [GO] 2020―Jul―29 COVID-19 and skin cancer management: French nation-wide questionnaire survey from real-life practice Charlée Nardin, Eve Puzenat, Sophie Dalac, Eve Maubec, François Aubin
31 [GO] 2020―Jul―29 Treatment of Severe Pemphigus vulgaris during COVID-19 pandemic Yashdeep Singh Pathania, Abhishek Bhardwaj
32 [GO] 2020―Jul―29 Nonsteroidal anti-inflammatory drugs (NSAIDs) consideration by dermatologists during the COVID19 pandemic Mohamed L. Elsaie, Mohammad Jafferany, Etleva Jorgaqi
33 [GO] 2020―Jul―29 Egyptian Dermatologists Attitude towards Telemedicine amidst the COVID19 Pandemic: A Cross-Sectional Study Mohamed L. Elsaie, Hany A Shehata, Noha S Hanafi, Shady M Ibrahim, Hany S Ibrahim, Ayman Abdelmaksoud
34 [GO] 2020―Jul―24 The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies Federico Pirro, Giacomo Caldarola, Andrea Chiricozzi, Sara Tambone, Marco Mariani, Laura Calabrese, et al. (+3)
35 [GO] 2020―Jul―22 Rituximab: a safe therapeutic option during the COVID-19 pandemic? Ambra Di Altobrando, Annalisa Patrizi, Diego Abbenante, Federico Bardazzi
36 [GO] 2020―Jul―21 A case of severe psoriatic erythroderma with COVID-19 Fariba Ghalamkarpour, Mohammad Reza Pourani, Fahimeh Abdollahimajd, Omid Zargari
37 [GO] 2020―Jul―10 Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria Mohammed Shanshal
38 [GO] 2020―Jul―09 Patient's perspective: psychological burden of the COVID-19 pandemic in 146 psoriatic patients treated with biological drugs and small molecules in real clinical practice A. Rodríguez-Villa Lario, D. Vega-Díez, M. González-Cañete, I. Polo-Rodríguez, A. B. Piteiro-Bermejo, M. Herrero-Fernández, et al. (+3)
39 [GO] 2020―Jul―09 Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas Chidubem A. V. Okeke, William D. Shipman, Jessica D. Perry, Michelle L. Kerns, Ginette A. Okoye, Angel S. Byrd
40 [GO] 2020―Jul―06 A probable atypical skin manifestation of COVID-19 infection Mohammad Shahidi Dadras, Omid Zargari, Rozita Abolghasemi, Ayda Bahmanjahromi, Fahimeh Abdollahimajd
41 [GO] 2020―Jul―06 COVID-19 related anagen effluvium Mohammed Shanshal
42 [GO] 2020―Jul―01 Cosmetic surgeries amidst pandemic area of COVID-19: suggested protocol Seyed-Naser Emadi, Amir Hooshang Ehsani, Kamran Balighi, Maryam Nasimi
43 [GO] 2020―Jun―30 Dermatological consultations in the COVID-19 era: Is teledermatology the key to social distancing? An Egyptian experience Pakinam I.N. Mostafa, Amira Ali Hegazy
44 [GO] 2020―Jun―30 The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian Red-Zone Laura Cristina Gironi, Paolo Boggio, Roberto Giorgione, Giovanni Damiani, Paola Savoia
45 [GO] 2020―Jun―29 COVID-19 and Psoriasis: Biologic Treatment and Challenges Ali Ebrahimi, Babak Sayad, Zohreh Rahimi
46 [GO] 2020―Jun―27 COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: A tele-medicine experience Mohammad Shahidi-Dadras, Fahimeh Abdollahimajd, Laya Ohadi, Mohammadreza Tabary, Farnaz Araghi, Nikoo Mozafari, et al. (+2)
47 [GO] 2020―Jun―27 Herpes zoster cases increased during COVID-19 outbreak. Is it possible a relation? Goksen Ertugrul, Habibullah Aktas
48 [GO] 2020―Jun―27 Epidermolysis bullosa and the COVID-19 pandemic: challenges and recommendations Hassan Vahidnezhad, Hamideh Moravvej, Ayda Bahmanjahromi, Leila Youssefian, Fahimeh Abdollahimajd
49 [GO] 2020―Jun―27 Treatment of Psoriasis - Unburdened by Fear During SARS-CoV2 Menace Teodora-Larisa Timis, Ioan-Alexandru Florian, Stefan-Cristian Vesa, Remus-Ioan Orasan
50 [GO] 2020―Jun―26 COVID-19 effect on phototherapy treatment utilization in dermatology S. Fisher, M. Ziv
51 [GO] 2020―Jun―22 Phototherapy and vitamin D: the importance in COVID-19 era Matteo Megna, Gabriella Fabbrocini, Alessia Villani
52 [GO] 2020―Jun―22 Clinical management of psoriasis patients during the COVID-19 pandemic Vipawee S. Chat, Shelley K. Uppal, Donovan G. Kearns, Jashin J. Wu
53 [GO] 2020―Jun―22 Organization of biologic therapy during the COVID-19 pandemic based on example of Dermatology Clinic Centre of Postgraduate Medical Education in Warsaw Klaudia Dopytalska, Agata Mikucka-Wituszyńska, Piotr Ciechanowicz, Michał Szczerba, Elżbieta Szymańska, Irena Walecka
54 [GO] 2020―Jun―22 Psoriasis and COVID-19: a multifactorial consideration Jeffrey M. Cohen, Lourdes M. Perez-Chada, Dimitri De Kouchkovsky, Jeff R. Gehlhausen
55 [GO] 2020―Jun―16 Psoriasis and risk of the COVID-19 infection: Is there a role for Angiotensin Converting Enzyme (ACE)? Mohammad Shahidi-Dadras, Mohammadreza Tabary, Reza M Robati, Farnaz Araghi, Sahar Dadkhahfar
56 [GO] 2020―Jun―13 Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic Ömer Kutlu, Habibullah Aktaş, Işıl Göğem İmren, Ahmet Metin
57 [GO] 2020―Jun―10 Recommendations on trichological treatments during COVID-19 pandemic Alfredo Rossi, Francesca Magri, Gemma Caro, Alessandro Federico, Marco Di Fraia, Marta Muscianese, et al. (+2)
58 [GO] 2020―Jun―05 Challenges faced by patients with morphea in the era of SARS-CoV-2 Mohammad Shahidi Dadras, Nastaran Namazi, Mohammad Nikvar, Fahimeh Abdollahimajd
59 [GO] 2020―May―27 Use of systemic therapies for psoriasis in the COVID-19 era Donovan G. Kearns, Shelley Uppal, Vipawee S. Chat, Jashin J. Wu
60 [GO] 2020―May―21 Dermatology Department: What we could do amidst the pandemic of COVID-19? Robabeh Abedini, Narges Ghandi, Vahideh Lajevardi, Maryam Ghiasi, Maryam Nasimi
61 [GO] 2020―May―20 Is Biologic Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic Different from Psoriasis Biologic Treatment? Elia Rosi, Nicola Pimpinelli, Francesca Prignano
62 [GO] 2020―May―18 Management Strategies of Autoimmune bullous diseases during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19) Pan Chen, Guiying Zhang, Yi Zhan
63 [GO] 2020―May―18 Safety of dupilumab in atopic patients during COVID-19 outbreak Maddalena Napolitano, Cataldo Patruno, Angelo Ruggiero, Mariateresa Nocerino, Gabriella Fabbrocini
64 [GO] 2020―May―18 Reorganization of a Northern Italy dermatology department during the COVID-19 pandemic: is it temporary or the beginning of a new era in dermatology? M. Valenti, L. Gargiulo, G. Pavia, P. Facheris, R. Borroni, A. Narcisi, A. Costanzo
65 [GO] 2020―May―14 Biologics for patients affected by Hidradenitis suppurativa in the COVID-19 era: data from a referral centre of Southern Italy Claudio Marasca, Angelo Ruggiero, Matteo Megna, Maria Carmela Annunziata, Gabriella Fabbrocini
66 [GO] 2020―May―14 A survey of psoriasis patients on biologics during COVID-19: a single centre experience M. Burlando, L. Carmisciano, E. Cozzani, A. Parodi
67 [GO] 2020―May―04 Inpatient Teledermatology During the COVID-19 Pandemic Kyle Rismiller, Alexander M. Cartron, John C. L. Trinidad
68 [GO] 2020―May―02 A challenging case of psoriasis flare-up after COVID-19 infection Soheila Nasiri, Farnaz Araghi, Mohammadreza Tabary, Mehdi Gheisari, Zahra Mahboubi-Fooladi, Sahar Dadkhahfar
69 [GO] 2020―May―02 Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case-report Maryam Daneshpazhooh, Tahereh Soori, Ahdie Isazade, Pedram Noormohammadpour
70 [GO] 2020―Apr―29 The Danger of Neglecting Melanoma during the COVID-19 Pandemic Tamar Gomolin, Abigail Cline, Marc Zachary Handler
71 [GO] 2020―Apr―28 Conducting Clinical Trials During the COVID-19 Pandemic EK. Collier, JL. Hsiao, VY. Shi
72 [GO] 2020―Apr―23 Immunomodulators and immunosuppressants in the era of SARS-CoV-2 - could laboratory tests be the missing link? Miguel Alpalhão, Paulo Filipe
73 [GO] 2020―Apr―17 Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears M. Megna, A. Ruggiero, C. Marasca, G. Fabbrocini
74 [GO] 2020―Apr―13 The management of biologics in dermatologic patients in the 2019-nCoV era Kerasia-Maria Plachouri, Sophia Georgiou
75 [GO] 2020―Apr―08 SECURE-Psoriasis: a de-identified registry of psoriasis patients diagnosed with COVID-19 Esther A. Balogh, Courtney Heron, Steven R. Feldman, William W. Huang
76 [GO] 2020―Apr―07 Biological treatment use amid the COVID-19 era, a close look at the unresolved perplexity Mohammed Shanshal
77 [GO] 2020―Apr―06 Biologic therapy for psoriasis during the covid-19 outbreak is not a choice Federico Bardazzi, Camilla Loi, Lidia Sacchelli, Ambra Di Altobrando
78 [GO] 2020―Apr―03 COVID-19: Challenges and opportunities for dermatology response S Chawla
79 [GO] 2020―Apr―02 Teledermatology: a useful tool to fight COVID-19 Alessia Villani, Massimiliano Scalvenzi, Gabriella Fabbrocini
80 [GO] 2020―Apr―02 An Assessment of United States Dermatology Practices during the COVID-19 Outbreak Suraj Muddasani, Anne Housholder, Alan B. Fleischer
81 [GO] 2020―Mar―28 Biological treatment during COVID-19 outbreak Won Sriwijitalai, Viroj Wiwanitkit
82 [GO] 2020―Mar―19 Should patients stop their biologic treatment during the COVID-19 pandemic Arjun M. Bashyam, Steven R. Feldman

82 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.015 sec